Therapeutic decisions in ALS patients: cross-cultural differences and clinical implications

被引:40
作者
Andersen, Peter M. [1 ]
Kuzma-Kozakiewicz, Magdalena [2 ,3 ]
Keller, Juergen [4 ]
Aho-Oezhan, Helena E. A. [4 ]
Ciecwierska, Katarzyna [2 ]
Szejko, Natalia [2 ]
Vazquez, Cynthia [4 ]
Boehm, Sarah [4 ]
Badura-Lotter, Gisela [5 ]
Meyer, Thomas [6 ]
Petri, Susanne [7 ]
Linse, Katharina [8 ]
Hermann, Andreas [8 ]
Semb, Olof [9 ]
Stenberg, Erica [1 ]
Nackberg, Simona [9 ]
Dorst, Johannes [4 ]
Uttner, Ingo [4 ]
Haggstrom, Ann-Cristin [1 ]
Ludolph, Albert C. [4 ]
Lule, Dorothee [4 ]
机构
[1] Umea Univ, Inst Pharmacol & Clin Neurosci, Umea, Sweden
[2] Med Univ Warsaw, Dept Neurol, Warsaw, Poland
[3] Med Univ Warsaw, Neurodegenerat Dis Res Grp, Warsaw, Poland
[4] Univ Ulm, Dept Neurol, Ulm, Germany
[5] Univ Ulm, Dept Hist & Eth Med, Ulm, Germany
[6] Charite CVK, Dept Neurol, Berlin, Germany
[7] Hannover Med Sch, Dept Neurol, Hannover, Germany
[8] Tech Univ Dresden, Germany & German Ctr Neurodegenerat Dis DZNE, Dept Neurol, Dresden, Germany
[9] Umea Univ, Dept Clin Sci, Umea, Sweden
关键词
Decision; Amyotrophic lateral sclerosis; Palliative care; Quality of life; Medical care; Culture; AMYOTROPHIC-LATERAL-SCLEROSIS; QUALITY-OF-LIFE; NONINVASIVE VENTILATION; CARE; GASTROSTOMY; SURVIVAL; DISEASE; DIE;
D O I
10.1007/s00415-018-8861-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Quantitative analysis of decision-making on therapeutic options in different sociocultural context in amyotrophic lateral sclerosis (ALS). ALS patients (n = 244) were consecutively recruited in Germany (n = 83), Poland (n = 83), and Sweden (n = 78) in a prospective cross-cultural study (www.NEEDSinALS.com). They were interviewed on preferences for therapeutic techniques including invasive (IV) and non-invasive ventilation (NIV), as well as percutaneous endoscopic gastrostomy (PEG) and on hypothetical termination of these using quantitative questions. Using standardized questionnaires, religiousness, personal values, quality of life, and depressiveness were assessed. NIV was most frequently used in Germany and PEG in Sweden. Swedish patients were most liberal on initiation and termination of PEG, NIV and IV. Polish patients were mostly undecided and were least likely to consider discontinuing supportive management. Current use was partly associated with age, gender and state of physical function; also, financial support explained some variance. Future preferences on therapeutic options from the patient's perspective were also closely associated with cultural factors. The more oriented towards traditional and conservative values, the less likely patients were to decide for invasive therapeutic devices (IV, PEG), the least likely to have ideations to discontinue any device and the more likely to have an undecided attitude. Current use of therapeutic options is determined by medical condition in analogy to clinical guidelines. For future considerations, other factors such as cultural background are crucial, yielding hurdles to be regarded in the implementation of advanced directives in a multicultural environment.
引用
收藏
页码:1600 / 1606
页数:7
相关论文
共 30 条
[1]   Wish to die in end-stage ALS [J].
Albert, SM ;
Rabkin, JG ;
Del Bene, ML ;
Tider, T ;
O'Sullivan, I ;
Rowland, LP ;
Mitsumoto, H .
NEUROLOGY, 2005, 65 (01) :68-74
[2]   EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) - revised report of an EFNS task force [J].
Andersen, Peter M. ;
Abrahams, Sharon ;
Borasio, Gian D. ;
de Carvalho, Mamede ;
Chio, Adriano ;
Van Damme, Philip ;
Hardiman, Orla ;
Kollewe, Katja ;
Morrison, Karen E. ;
Petri, Susanne ;
Pradat, Pierre-Francois ;
Silani, Vincenzo ;
Tomik, Barbara ;
Wasner, Maria ;
Weber, Markus .
EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (03) :360-E24
[3]   Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation - A clinical and genealogical study of 36 patients [J].
Andersen, PM ;
Forsgren, L ;
Binzer, M ;
Nilsson, P ;
AlaHurula, V ;
Keranen, ML ;
Bergmark, L ;
Saarinen, A ;
Haltia, T ;
Tarvainen, I ;
Kinnunen, E ;
Udd, B ;
Marklund, SL .
BRAIN, 1996, 119 :1153-1172
[4]   How to get serious answers to the serious question: 'How have you been?': Subjective quality of life (QOL) as an individual experiential emergent construct [J].
Bernheim, JL .
BIOETHICS, 1999, 13 (3-4) :272-287
[5]   MEDICAL DECISIONS ARE INDEPENDENT OF COGNITIVE IMPAIRMENT IN AMYOTROPHIC LATERAL SCLEROSIS [J].
Bohm, Sarah ;
Aho-Ozhan, Helena E. A. ;
Keller, Jurgen ;
Dorst, Johannes ;
Uttner, Ingo ;
Ludolph, Albert C. ;
Lule, Dorothee .
NEUROLOGY, 2016, 87 (16) :1737-1738
[6]   Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey [J].
Borasio, GD ;
Shaw, PJ ;
Hardiman, O ;
Ludolph, AC ;
Luis, MLS ;
Silani, V .
AMYOTROPHIC LATERAL SCLEROSIS, 2001, 2 (03) :159-164
[7]   Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis [J].
Bourke, SC ;
Tomlinson, M ;
Williams, TL ;
Bullock, RE ;
Shaw, PJ ;
Gibson, GJ .
LANCET NEUROLOGY, 2006, 5 (02) :140-147
[8]   The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function [J].
Cedarbaum, JM ;
Stambler, N ;
Malta, E ;
Fuller, C ;
Hilt, D ;
Thurmond, B ;
Nakanishi, A .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 169 (1-2) :13-21
[9]   End-of-life management in patients with amyotrophic lateral sclerosis [J].
Connolly, Sheelah ;
Galvin, Miriam ;
Hardiman, Orla .
LANCET NEUROLOGY, 2015, 14 (04) :435-442
[10]   Nutritional status is a prognostic factor for survival in ALS patients [J].
Desport, JC ;
Preux, PM ;
Truong, TC ;
Vallat, JM ;
Sautereau, D ;
Couratier, P .
NEUROLOGY, 1999, 53 (05) :1059-1063